Katia Karalis
Company: Regeneron Pharmaceuticals Inc
Job title: Executive Director
Seminars:
Evaluating Reverse-Translating Human Target Evidence to Investigate in Preclinical Models 11:00 am
Successful translation into the clinic remains a major hurdle in the neuroimmunology field. Join this workshop to discuss the debate the back translation of human target evidence to investigate and validate in preclinical models. Workshop highlights include: • Exploring challenges and achievements of reversetranslation in glial target validation • Using human evidence from genetic and…Read more
day: Pre-Conference Day Track B 2